347850 Stock Chart & Stats
₩64800.00
₩8,100.00(14.29%)
―
--
Day’s Range― - ―
52-Week Range₩32,100.00 - ₩116,600.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.61M
Market Cap
₩2.31T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding45,837,610
10 Day Avg. Volume1,231,291
30 Day Avg. Volume1,606,802
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2,675,477.24
Revenue Forecast (FY)₩24.23T
347850 FAQ
What was D&D Pharmatech Co., Ltd.’s price range in the past 12 months?
D&D Pharmatech Co., Ltd. lowest stock price was ₩32100.00 and its highest was ₩116600.00 in the past 12 months.
What is D&D Pharmatech Co., Ltd.’s market cap?
D&D Pharmatech Co., Ltd.’s market cap is ₩2.31T.
When is D&D Pharmatech Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were D&D Pharmatech Co., Ltd.’s earnings last quarter?
D&D Pharmatech Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩217.714 earnings per share for the quarter, missing the consensus estimate of N/A by -₩217.714.
Is D&D Pharmatech Co., Ltd. overvalued?
According to Wall Street analysts D&D Pharmatech Co., Ltd.’s price is currently Undervalued.
Does D&D Pharmatech Co., Ltd. pay dividends?
D&D Pharmatech Co., Ltd. does not currently pay dividends.
What is D&D Pharmatech Co., Ltd.’s EPS estimate?
D&D Pharmatech Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does D&D Pharmatech Co., Ltd. have?
D&D Pharmatech Co., Ltd. has 45,837,610 shares outstanding.
What happened to D&D Pharmatech Co., Ltd.’s price movement after its last earnings report?
D&D Pharmatech Co., Ltd. reported an EPS of -₩217.714 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.291%.
Which hedge fund is a major shareholder of D&D Pharmatech Co., Ltd.?
Currently, no hedge funds are holding shares in KR:347850
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
GC Biopharma Corp.
―
Hanmi Science Co., Ltd
―
Celltrion Pharm Inc.
―
Mezzion Pharma Co., Ltd.
―
PharmaResearch Co., Ltd.
―